Young Blood Factors Can Reverse Brain Aging and Restore Memory Function
Stanford researcher reveals how proteins in young blood can rejuvenate aging brains and improve cognition.
Summary
Dr. Tony Wyss-Coray from Stanford discusses groundbreaking research showing that factors in young blood can reverse brain aging and restore memory function in older organisms. His team used parabiosis experiments, surgically connecting young and old mice to share blood circulation, demonstrating that young blood reactivates brain stem cells, reduces inflammation, and improves cognitive function. The research has progressed to human trials using plasma fractions from young donors, showing promising results in Alzheimer's and Parkinson's patients. Wyss-Coray explains how aging occurs non-uniformly across organs, with some aging faster than others, and introduces organ-specific aging clocks that can predict disease risk years in advance.
Detailed Summary
This episode features Dr. Tony Wyss-Coray, a Stanford neurology professor pioneering research into blood-based rejuvenation therapies. His work demonstrates that young blood contains specific proteins that can reverse key features of brain aging, including improved cognition and tissue recovery from damage.
The conversation covers Wyss-Coray's parabiosis experiments where young and old mice share blood circulation, resulting in reactivated brain stem cells, reduced inflammation, and improved memory function in older animals. Human studies using plasma fractions from young donors have shown promising results in small trials with Alzheimer's and Parkinson's patients, with one 500-patient study demonstrating clear cognitive benefits.
A crucial insight is that organs age at different rates within the same individual. Wyss-Coray's company, Vero Biosciences, has developed organ-specific aging clocks that measure thousands of blood proteins to determine the biological age of specific organs. This technology can predict disease risk years in advance - if your heart ages faster than your chronological age, you're more likely to develop heart disease.
The discussion also addresses popular longevity supplements like NAD+ precursors (NMN, NR), noting that while they show promise in animal studies, no human intervention has been proven to extend lifespan. Many supplements lack quality control, with studies showing that half don't contain what's listed on labels. The researchers emphasize that exercise and proper diet remain the only validated interventions for healthy aging, while blood-based therapies represent the next frontier in rejuvenation medicine.
Key Findings
- Young blood factors can reactivate brain stem cells and improve memory function in aging organisms
- Organs age at different rates within individuals, creating predictable disease risk patterns
- Blood protein analysis can predict organ-specific aging and future disease risk years in advance
- Plasma exchange therapy shows cognitive benefits in Alzheimer's patients in controlled trials
- No supplement including NAD+ precursors has proven lifespan extension in humans despite animal studies
Methodology
This is a detailed interview from the Huberman Lab podcast, featuring Stanford neurology professor Dr. Tony Wyss-Coray discussing peer-reviewed research and ongoing clinical trials. The conversation covers both published animal studies and human clinical trial data.
Study Limitations
Most rejuvenation research remains in animal models or small human trials. The specific mechanisms and optimal protocols for blood-based therapies are still being investigated. Supplement quality varies significantly across manufacturers.
Enjoyed this summary?
Get the latest longevity research delivered to your inbox every week.